Ken Moseley, Senior VP and General Counsel at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 3,500 shares at $20.00 ($70K) on 2016-09-16, disclosed to the SEC on 2016-09-20.
Open-market sale of $70k BLCM by Senior VP and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 700 | $14K | 20.0% |
| 2 | $20.01 | 1,300 | $26K | 37.1% |
| 3 | $20.01 | 1,300 | $26K | 37.2% |
| 4 | $20.00 | 200 | $4K | 5.7% |
| Total | $20.01 avg | 3,500 | $70K | 100% |
| Filing → |
| BLCM | SELL | 2016-08-17 | $20K | — | Filing → |
| BLCM | SELL | 2016-06-06 | $195K | — | Filing → |
| BLCM | SELL | 2015-11-04 | $195K | — | Filing → |